Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aceragen (ACGN)
NASDAQ:ACGN
Holding ACGN?
Track your performance easily
ACGN Stock Chart & Stats
Day’s Range$0.38 - $0.44
52-Week Range― - ―
Previous Close$0.44
Volume53.00K
Average Volume (3M)N/A
Market Cap
$3.20M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aceragen News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACGN FAQ
What was Aceragen’s price range in the past 12 months?
Currently, no data Available
What is Aceragen’s market cap?
Currently, no data Available
When is Aceragen’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aceragen’s earnings last quarter?
Currently, no data Available
Is Aceragen overvalued?
According to Wall Street analysts Aceragen’s price is currently Overvalued.
Does Aceragen pay dividends?
Aceragen does not currently pay dividends.
What is Aceragen’s EPS estimate?
Aceragen’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aceragen have?
Currently, no data Available
What happened to Aceragen’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aceragen?
Currently, no hedge funds are holding shares in ACGN
---
Aceragen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Aceragen
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.
---
ACGN Stock 12 Month Forecast
Average Price Target
―Forte Biosciences
―
RegeneRx Biopharmaceuticals
―
bioAffinity Technologies, Inc.
―
Neoleukin Therapeutics
―
AgeX Therapeutics
―
Best Analysts Covering ACGN
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-91.60%
reiterated a buy rating 2 years ago
Copying Roy Buchanan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -91.60% per trade.
---